Novel Method Helps Prevent Senescence and Enhances Biomolecule Production

Researchers from the University of Illinois have developed a novel approach for preventing the senescence of stem cells and maintaining their productivity. Stem cells, known for their ability to differentiate into various cell types, undergo senescence as they age, hindering their use in therapeutic cell cultures. The team's new method involves delivering antioxidants to stem cells using polymer-stabilized crystals, ensuring reliable and long-lasting antioxidant release with minimal variation.

The traditional use of antioxidants to delay senescence has been limited by inconsistent drug release and varying efficacy. However, the team's study, published in Advanced Functional Materials, demonstrates that microfluidics technology can be employed to create uniformly sized crystals within which antioxidants are embedded. This approach minimizes variation in drug release rates, as each drop functions as a small reactor producing similar-sized crystals. Moreover, the crystals dissolve at a slower rate compared to conventional methods, enabling a uniform and extended release of antioxidants over time.

The improved drug release profile achieved through this method is crucial for maintaining optimal drug concentrations in the cell culture media. While typical antioxidants lose their effectiveness within six hours, the new antioxidant crystals remain bioactive for at least two days. This extended duration not only reduces the frequency of adding antioxidants to the culture media but also minimizes the variation in biomolecule production by stem cells, addressing a major challenge in biomanufacturing.

Prolonging the efficacy of the delivered antioxidants keeps stem cell cultures in a non-senescent state for a longer period, leading to a higher yield of biomolecules required for therapeutic applications. Additionally, the team envisions using this method for patient-derived stem cell treatments, where biomolecules from the patient's own body are utilized to address tissue ailments. By reverting senescent cells to a healthy state, a larger quantity of therapeutically relevant biomolecules can be harvested for elderly patients, who typically have a higher proportion of senescent cells.

The researchers emphasize that this methodology holds potential beyond antioxidant delivery to stem cell cultures. Since most cell types experience senescence, the technique can be applied to other cell cultures relevant to medicine and therapeutics. Furthermore, the crystals may serve as a means to deliver sustained and controlled levels of antioxidants or other drugs directly to target tissues within patients.